Regulation of the gene encoding tumor necrosis factor alpha (TNF-alpha) inthe rat brain and pituitary in response to different models of systemic immune challenge
S. Nadeau et S. Rivest, Regulation of the gene encoding tumor necrosis factor alpha (TNF-alpha) inthe rat brain and pituitary in response to different models of systemic immune challenge, J NE EXP NE, 58(1), 1999, pp. 61-77
Citations number
49
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
Tumor necrosis factor (TNF)-alpha is usually referred to as a proinflammato
ry cytokine that plays a central role in initiating the cascade of other cy
tokines and factors for an appropriate immune response to infection. Like s
ystemic phagocytes, recent studies have reported that specific cellular pop
ulations of the CNS have the ability to express and release the proinflamma
tory cytokine in response to peripheral administration of the bacterial end
otoxin lipopolysaccharide (LPS). Whether such phenomenon represents a gener
al mechanism of systemic immunogenic stimuli and how the severity of the ch
allenge may influence TNF-alpha transcription in the brain has yet to be de
fined. Adult male rats were sacrificed 1, 3, 6, 12, 24 and 48 hours (h) aft
er intraperitoneal (IP) injection of LPS (25-250 mu g/100 g) or intramuscul
ar (IM) injection of turpentine. Brains and pituitary glands were removed,
cut, and TNF-alpha mRNA assayed by in situ hybridization using a full-lengt
h rat cRNA probe. The results show no positive signal under basal condition
s or following sterile inflammation into the left hind limb. Systemic LPS c
aused a profound increase in the expression of the gene encoding TNF-alpha
in the leptomeninges, choroid plexus (chp) and all sensorial circumventricu
lar organs (CVOs). Interestingly, a migratory-like pattern of TNF-alpha-pos
itive cells became apparent around the sensorial CVOs at 3 h, while a ubiqu
itous-like positive signal was found throughout the brain 6 h after the inj
ection with the highest dose of LPS. The IP LPS injection also stimulated T
NF-alpha. transcription in the anterior pituitary lobe; the signal was maxi
mal 1 h after the injection and returned gradually to basal levels at 12 h,
whereas the mRNA encoding the cytokine was detected later in the neurohypo
physis, i.e. 3 and 6 h post challenge. Dual-labeling procedure provided the
evidence of an LPS-dependent induction of TNF-alpha in different phagocyti
c cellular populations of the brain, including parenchymal micro,microglial
cells during severe endotoxemia. The fact that these myeloid-derived cells
have the ability to express the LPS receptor CD14 in the brain may well ex
plain the transcriptional activation of the cytokine in response to the bac
terial endotoxin, but not to systemic localized inflammation.